Literature DB >> 21350707

Role of the endothelium in inflammatory bowel diseases.

Walter E Cromer1, J Michael Mathis, Daniel N Granger, Ganta V Chaitanya, J Steven Alexander.   

Abstract

Inflammatory bowel diseases (IBD) are a complex group of diseases involving alterations in mucosal immunity and gastrointestinal physiology during both initiation and progressive phases of the disease. At the core of these alterations are endothelial cells, whose continual adjustments in structure and function coordinate vascular supply, immune cell emigration, and regulation of the tissue environment. Expansion of the endothelium in IBD (angiogenesis), mediated by inflammatory growth factors, cytokines and chemokines, is a hallmark of active gut disease and is closely related to disease severity. The endothelium in newly formed or inflamed vessels differs from that in normal vessels in the production of and response to inflammatory cytokines, growth factors, and adhesion molecules, altering coagulant capacity, barrier function and blood cell recruitment in injury. This review examines the roles of the endothelium in the initiation and propagation of IBD pathology and distinctive features of the intestinal endothelium contributing to these conditions.

Entities:  

Keywords:  Adhesion molecules; Chemokines; Crohn’s disease; Cytokines; Endothelium; Growth factors; Inflammation; Microvasculature; Nitric oxide; Ulcerative colitis

Mesh:

Substances:

Year:  2011        PMID: 21350707      PMCID: PMC3040330          DOI: 10.3748/wjg.v17.i5.578

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  244 in total

1.  ADAM15 upregulation and interaction with multiple binding partners in inflammatory bowel disease.

Authors:  Jean-François Mosnier; Anne Jarry; Chantal Bou-Hanna; Marc G Denis; Didier Merlin; Christian L Laboisse
Journal:  Lab Invest       Date:  2006-08-07       Impact factor: 5.662

Review 2.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

3.  Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells.

Authors:  I Kim; S O Moon; S H Kim; H J Kim; Y S Koh; G Y Koh
Journal:  J Biol Chem       Date:  2000-12-06       Impact factor: 5.157

4.  Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis.

Authors:  Jesús Rivera-Nieves; Johnson Ho; Giorgos Bamias; Natalia Ivashkina; Klaus Ley; Martin Oppermann; Fabio Cominelli
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

5.  TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis.

Authors:  B Del Zotto; G Mumolo; A M Pronio; C Montesani; R Tersigni; M Boirivant
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

6.  Sodium butyrate inhibits angiogenesis of human intestinal microvascular endothelial cells through COX-2 inhibition.

Authors:  Hitoshi Ogawa; Parvaneh Rafiee; Pamela J Fisher; Nathan A Johnson; Mary F Otterson; David G Binion
Journal:  FEBS Lett       Date:  2003-11-06       Impact factor: 4.124

Review 7.  Anti-angiogenic therapies for metastatic colorectal cancer.

Authors:  Anna Dorothea A D W Wagner; Dirk Arnold; Axel A G Grothey; Johannes Haerting; Susanne Unverzagt
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

8.  Clinical relevance of circulating midkine in ulcerative colitis.

Authors:  Malgorzata Krzystek-Korpacka; Katarzyna Neubauer; Malgorzata Matusiewicz
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

9.  Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion.

Authors:  K L Davenpeck; T W Gauthier; K H Albertine; A M Lefer
Journal:  Am J Physiol       Date:  1994-08

10.  The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice.

Authors:  Frank Michael Klenke; Martha-Maria Gebhard; Volker Ewerbeck; Amir Abdollahi; Peter E Huber; Axel Sckell
Journal:  BMC Cancer       Date:  2006-01-12       Impact factor: 4.430

View more
  58 in total

1.  Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability.

Authors:  Charu Munjal; Neetu Tyagi; David Lominadze; Suresh C Tyagi
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

2.  What's hot in inflammatory bowel disease in 2011?

Authors:  Silvio Danese
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 3.  Interaction of endothelial cells with macrophages-linking molecular and metabolic signaling.

Authors:  Joanna Kalucka; Laura Bierhansl; Ben Wielockx; Peter Carmeliet; Guy Eelen
Journal:  Pflugers Arch       Date:  2017-02-24       Impact factor: 3.657

Review 4.  A bright future? Optogenetics in the periphery for pain research and therapy.

Authors:  Aaron D Mickle; Robert W Gereau
Journal:  Pain       Date:  2018-09       Impact factor: 6.961

5.  Decrease of guanylyl cyclase β1 subunit and nitric oxide (NO)-induced relaxation in mouse rectum with colitis and its reproduction on long-term NO treatment.

Authors:  Yuri Hamada; Erina Kato; Hiroyuki Nakamura; Hiromichi Fujino; Kenjiro Matsumoto; Kimihito Tashima; Shunji Horie; Toshihiko Murayama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

6.  IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption.

Authors:  Victoria Langer; Eugenia Vivi; Daniela Regensburger; Thomas H Winkler; Maximilian J Waldner; Timo Rath; Benjamin Schmid; Lisa Skottke; Somin Lee; Noo Li Jeon; Thomas Wohlfahrt; Viktoria Kramer; Philipp Tripal; Michael Schumann; Stephan Kersting; Claudia Handtrack; Carol I Geppert; Karina Suchowski; Ralf H Adams; Christoph Becker; Andreas Ramming; Elisabeth Naschberger; Nathalie Britzen-Laurent; Michael Stürzl
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

7.  For Application to Human Spaceflight and ISS Experiments: VESGEN Mapping of Microvascular Network Remodeling during Intestinal Inflammation.

Authors:  Patricia Parsons-Wingerter; Hans-Christian Reinecker
Journal:  Gravit Space Biol Bull       Date:  2012-10-01

8.  Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases.

Authors:  Daniel Marbach; David Lamparter; Gerald Quon; Manolis Kellis; Zoltán Kutalik; Sven Bergmann
Journal:  Nat Methods       Date:  2016-03-07       Impact factor: 28.547

9.  GPR4 deficiency alleviates intestinal inflammation in a mouse model of acute experimental colitis.

Authors:  Edward J Sanderlin; Nancy R Leffler; Kvin Lertpiriyapong; Qi Cai; Heng Hong; Vasudevan Bakthavatchalu; James G Fox; Joani Zary Oswald; Calvin R Justus; Elizabeth A Krewson; Dorcas O'Rourke; Li V Yang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-12-07       Impact factor: 5.187

10.  IL-1α-induced microvascular endothelial cells promote neutrophil killing by increasing MMP-9 concentration and lysozyme activity.

Authors:  Xiaoye Liu; Hong Dong; Mingming Wang; Ying Gao; Tao Zhang; Ge Hu; Huiqing Duan; Xiang Mu
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.